Investigating discrepancies in demand and access for bariatric surgery across different demographics in the COVID-19 era

Mehta, Aashna; Awuah, Wireko Andrew; Kalmanovich, Jacob; Huang, Helen; Tanna, Resham; Iqbal, Duaa Javed; Garg, Tulika; Bulut, Halil İbrahim; Abdul‐Rahman, Toufik; Hasan, Mohammad Mehedi

doi:10.1016/j.amsu.2022.104368

Cited by 1 publication

(2 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The long‐term effects of COVID‐19 symptoms and its detrimental impact on CV care pose a major burden in healthcare systems worldwide. The impact of the COVID‐19 pandemic has been discussed in multiple conditions needing continuous long‐term management, ranging from bariatric surgery patients to individuals with acute myocardial infarction, arrhythmias, and cardiac arrest 13–15 . Nevertheless, it is paramount to disseminate the impact of the pandemic on CV prevention in FH patients to improve future risk‐stratification protocols and raise awareness amongst clinicians.…”

Section: Introductionmentioning

confidence: 99%

“…The impact of the COVID-19 pandemic has been discussed in multiple conditions needing continuous long-term management, ranging from bariatric surgery patients to individuals with acute myocardial infarction, arrhythmias, and cardiac arrest. [13][14][15] Nevertheless, it is paramount to disseminate the impact of the pandemic on CV prevention in FH patients to improve future risk-stratification protocols and raise awareness amongst clinicians. With the emerging public health concern of FH patients, this review aims to highlight the direct and indirect impact of the COVID-19 pandemic on CV outcomes in FH.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic

Huang

Leung

Garg

et al. 2023

Clinical Cardiology

Self Cite

View full text Add to dashboard Cite

Familial hypercholesterolemia (FH) is a hereditary condition caused by mutations in the lipid pathway. The goal in managing FH is to reduce circulating low‐density lipoprotein cholesterol and, therefore, reduce the risk of developing atherosclerotic cardiovascular disease (ASCVD). Because FH patients were considered high risk groups due to an increased susceptible for contracting COVID‐19 infection, we hypothesized whether the effects of the pandemic hindered access to cardiovascular care. In this review, we conducted a literature search in databases Pubmed/Medline and ScienceDirect. We included a comprehensive analysis of findings from articles in English related and summarized the effects of the pandemic on cardiovascular care through direct and indirect effects. During the COVID‐19 pandemic, FH patients presented with worse outcomes and prognosis, especially those that have suffered from early ASCVD. This caused avoidance in seeking care due to fear of transmission. The pandemic severely impacted consultations with lipidologists and cardiologists, causing a decline in lipid profile evaluations. Low socioeconomic communities and ethnic minorities were hit the hardest with job displacements and lacked healthcare coverage respectively, leading to treatment nonadherence. Lock‐down restrictions promoted sedentary lifestyles and intake of fatty meals, but it is unclear whether these factors attenuated cardiovascular risk in FH. To prevent early atherogenesis in FH patients, universal screening programs, telemedicine, and lifestyle interventions are important recommendations that could improve outcomes in FH patients. However, the need to research in depth on the disproportionate impact within different subgroups should be the forefront of FH research.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%